241 – 250 of 2744
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
How to calculate ventricular–arterial coupling?
(
- Contribution to journal › Letter
-
Mark
Comment on : Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: Results from a national register-based cohort study. Reply
(
- Contribution to journal › Letter
-
Mark
Hypospadias repair can be associated with a hairy urethra. : Reply to a letter to the Editor concerning the publication "Postoperative outcomes in distal hypospadias : a meta-analysis of Mathieu and tubularized incised plate repair methods for the development of urethrocutaneous fistula and urethral stricture"
(
- Contribution to journal › Letter
-
Mark
Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
(
- Contribution to journal › Letter
-
Mark
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
(
- Contribution to journal › Letter
-
Mark
Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.1056/EVIDoa2200092
(
- Contribution to journal › Letter
-
Mark
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency : The IMCA1 Study of the EARCO Clinical Research Collaboration
(
- Contribution to journal › Letter
-
Mark
Global camera trap synthesis highlights the importance of protected areas in maintaining mammal diversity
(
- Contribution to journal › Letter
-
Mark
Springtime Stratospheric Volcanic Aerosol Impact on Midlatitude Cirrus Clouds
(
- Contribution to journal › Letter
-
Mark
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma : results from a Nordic Lymphoma Group phase II trial
(
- Contribution to journal › Letter